Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
NCT02390427 · COMPLETED · Phase 1
We track 1 ClinicalTrials.gov studies led by Otto Metzger Md. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Otto Metzger Md.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Otto Metzger Md currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Otto Metzger Md conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.